Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia

BACKGROUNDS: Chimeric antigen receptor (CAR)-T cell therapy has achieved unprecedented success in treating hematopoietic malignancies. However, this cell therapy is hampered in treating acute myeloid leukemia (AML) due to lack of ideal cell surface targets that only express on AML blasts and leukemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Gongqiang, Guo, Shanshan, Luo, Qian, Wang, Xiaoxia, Deng, Wenhai, Ouyang, Guifang, Pu, Jeffrey J., Lei, Wen, Qian, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950117/
https://www.ncbi.nlm.nih.gov/pubmed/36845088
http://dx.doi.org/10.3389/fimmu.2023.1093750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950117/
https://www.ncbi.nlm.nih.gov/pubmed/36845088
http://dx.doi.org/10.3389/fimmu.2023.1093750

Ejemplares similares